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There is a paucity of data regarding the clinical correlation of obesity and cirrhosis 
in a predominantly Hispanic population. Additionally, data is limited on the 
contribution of BMI to the incidence of liver cirrhosis in Hispanics in South Texas. 
The aim of this study is to assess the prevalence of liver cirrhosis and compare the 
prevalence between Hispanic and Non-Hispanics. In addition, these researchers 
seek to investigate the prevalence of liver cirrhosis stratified by body mass index. 
These researchers hypothesize that the prevalence of liver cirrhosis is higher 
amongst Hispanics than Non-Hispanics individuals, and that higher body mass index 




The obesity epidemic is a growing public health concern. According to the CDC, the 
overall prevalence of obesity in the United States was 39.8% in 2015- 2016.1 The 
prevalence of obesity is even higher in individuals of Hispanic origin (47.0%).1 In 
addition to the already known complications and comorbidities associated with 
obesity, data suggest that obesity is an independent risk factor for the development 
of liver disease.2,3 Obesity has been implicated as a risk factor for alcoholic-like 
inflammation, septal fibrosis, and progression to liver cirrhosis.2,4,5 The adipose 
tissue in obesity is proinflammatory, proangiogenic, and profibrogenic in hepatic 
tissue.6,7 A study from the United Kingdom found that an estimated 17% of cases of 
liver cirrhosis are attributable to excess body weight.8 Moreover, each 5 kg/m2 
increase in body mass index (BMI) was associated with about 30% higher risk of 
hepatic mortality.9  
 
Studies have found ethnic differences in the incidence of cirrhosis and rate of 
disease progression.10,11 Specifically, one study found a 4-fold higher prevalence of 
cirrhosis in Cameron County, Texas (0.94%) than the national prevalence (0.27%).11 
According to the United States Census Bureau, 89.9% of the population of Cameron 
County is Hispanic. Furthermore, in the United States, chronic liver disease and 
cirrhosis are the 7th leading cause of death in Hispanics, 11th in Non-  
Hispanics white, and 14thin Non-Hispanic blacks.12 These ethnic variations are 
likely due to a complex interplay between biological, social and behavioral factors.  
 
There is a paucity of data regarding the clinical correlation of obesity and cirrhosis 
in a predominantly Hispanic population. Additionally, data is limited on the 
contribution of BMI to the incidence of liver cirrhosis in Hispanics in South Texas. 
Therefore, the aim of this study is to investigate the prevalence of cirrhosis 
stratified by BMI in a predominately Hispanic population.  
 
Materials and Methods: 
 
This retrospective single-centered study has approval from the local institutional 
ethics and review board. Since this is a retrospective study, informed consent was 
waived. We retrospectively reviewed patient electronic medical records admitted to 
Valley Baptist Medical Center in Harlingen, Texas with cirrhosis between January 
2010 to January 2020 age > 18. In- hospital admission variables were collected 
through review of electronic medical records. These variables include basic 
demographic information, vital signs, social history, past medical history, and 
laboratory values. Additional data collected during hospital stay were also collected, 
such as abdominal imaging exams (e.g., ultrasound, CT of liver) and pathology 
results of liver biopsies.  
 
Demographics and presenting features of the patients on admission are illustrated 
in Table 1.  
FIGURES  
Table 1. Characteristics of patients.  
Variable Total Underweight Normal 
Weight 
Overweight Obese P 
value 
Female       
Male       
Age, years       
Hispanic       
Non-Hispanic       
Hypertension       
Hyperlipidemia       
Liver disease       
AST       
ALT       
Alkaline 
Phosphatase 
      
GGT       
Creatinine       
GFR       
Fasting plasma       
glucose 
Triglycerides       
LDL       
HDL       
HCV antibody       
HBV surface 
antigen 
      
Fasting insulin       
Platelets       




In a cohort of Hispanic patients in South Texas, the prevalence of cirrhosis/fibrosis 
was estimated to be 3.54%, and central obesity was an independent risk factor for 
cirrhosis/advanced fibrosis (p=0.04).11 Moderate to severe fibrosis has a 
statistically significant higher average BMI compared to those with none to mild 
fibrosis (p<0.001).14 A study in multiple Mexican regions found increased mortality 
from cirrhosis with statistically significant findings in the South and North regions 
(p<0.0001).15 Obesity only increased in the Central and Mexico City regions.15 
 
Obesity was an independent risk factor for cirrhosis and 65.3% of cirrhosis and 
advanced fibrosis cases may be attributable to obesity alone in a cohort of Hispanic 
patients.11 As South Texas has one of the highest rates of obesity in the United 
States, this population is susceptible to higher rates of liver disease, obesity and 
mortality.  
 
Hispanic patients that are obese have an increased risk of liver disease and 
associated mortality.11-16 These study findings are limited by the paucity of relevant 
research and variable methodology of the studies. Further research is needed to 
evaluate the impact of obesity on liver disease for this population. 
 
The main objective of the current study is to identify the prevalence of cirrhosis 
stratified by BMI in a predominately Hispanic population. Previous study by Jiao 
and colleagues observed a 4-fold higher prevalence of cirrhosis in Hispanics versus 
the general US population in South Texas.11 Therefore, these researchers also expect 
an increase in prevalence of cirrhosis in Hispanics compared to the US population. 
Previous studies have found an association between cirrhosis and body mass index, 
there is a lack in data in a predominantly Hispanic population.8,13 
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